Results 51 to 60 of about 814,420 (203)

Assessment of the expression pattern of a gene encoding plasma membrane pump under salt stress in the shoots of resistant and sensitive wheat cultivars and its wild relative, Aegilops crassa [PDF]

open access: yesمجله بیوتکنولوژی کشاورزی, 2015
Plasma membrane proton pump (H+-ATPase) has important roles in various physiological processes. Hence, the expression pattern of the gene which encodes a plasma membrane proton pump was surveyed in the shoots of resistant and sensitive wheat cultivars ...
Zahra Zinati   +3 more
doaj   +1 more source

Clopidogrel and proton pump inhibitors [PDF]

open access: yesCanadian Medical Association Journal, 2014
In their comprehensive review of antithrombotic agents following acute coronary syndromes, Matteau and Bhatt[1][1] discuss the drug interaction between proton pump inhibitors and clopidogrel. They note that the COGENT trial, led by Bhatt, found no increased risk of major cardiovascular events at ...
openaire   +2 more sources

Proton Pump Inhibitors: Omeprazole [PDF]

open access: yes, 2014
Characteristics and uses of proton pump inhibitors are discussed, specifically, the drug omeprazole, a type of proton pump inhibitor, is discussed, including the chemistry, it\u27s uses and side ...
Ongkowijoyo, Paulina N
core  

Refractory gastroesophageal reflux disease

open access: yesArquivos de Gastroenterologia, 2012
CONTEXT: Gastroesophageal reflux disease (GERD) is a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications.
Joaquim Prado P. Moraes-Filho
doaj   +1 more source

Proton Pump Inhibitors and Gastritis

open access: yesJournal of Clinical Biochemistry and Nutrition, 2008
Proton pump inhibitors (PPIs) are novel compounds that strongly inhibit the H(+)/K(+)-ATPase in the gastric parietal cells to cause profound suppression of acid secretion. Acid-generating ATPase, also known as vacuolar-type ATPase, is located in the lysozomes of leukocytes and osteoclasts and its activity is also reportedly influenced by treatment with
Suzuki, Masayuki   +2 more
openaire   +3 more sources

When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?

open access: yesThe Turkish Journal of Gastroenterology, 2017
Currently, proton pump inhibitors (PPIs) are widely used either over the counter or on prescription drugs. PPI’s are frequently used with other drugs when elderly and chronic desease burden population is taken to consideration.
Altay Çelebi, Hasan Yılmaz
doaj   +1 more source

Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events

open access: yesBMC Medicine, 2022
Background Approximately half of all women suffer from heartburn at some stage during pregnancy. The most effective treatment is proton pump inhibitors, but the safety of use during pregnancy cannot be guaranteed. This study aimed to elucidate the effect
Esmee M. Breddels   +6 more
doaj   +1 more source

The parietal cell gastric H, K-ATPase also functions as the Na, K-ATPase and Ca-ATPase in altered states [v2; ref status: indexed, http://f1000r.es/1tc]

open access: yesF1000Research, 2013
This article offers an explanation for the apparent lack of Na, K-ATPase activity in parietal cells although ouabain has been known to inhibit gastric acid secretion since 1962.
Tushar Ray
doaj   +1 more source

The gastric H, K-ATPase system also functions as the Na, K-ATPase and Ca-ATPase in altered states [v1; ref status: indexed, http://f1000r.es/1eo]

open access: yesF1000Research, 2013
This article offers an explanation for the apparent lack of Na, K-ATPase activity in parietal cells although ouabain has been known to inhibit gastric acid secretion since 1962.
Tushar Ray
doaj   +1 more source

Overprescribing proton pump inhibitors [PDF]

open access: yesBMJ, 2008
Proton pump inhibitors are one of the most frequently prescribed classes of drug in the world because they combine a high level of efficacy with low toxicity. In 2006, expenditure on these drugs was £425m (€595m; $872m) in England1 and £7bn globally.2 Yet studies consistently show that proton pump inhibitors are being overprescribed worldwide in both ...
Ian, Forgacs, Aathavan, Loganayagam
openaire   +2 more sources

Home - About - Disclaimer - Privacy